- Companies
- HC Surgical Specialists
HC Surgical Specialists Valuation Multiples
HC Surgical Specialists is valued at $41M as of October 2026, a 2.4x revenue multiple. In the last fiscal year, HC Surgical Specialists revenue was $15M and HC Surgical Specialists EBITDA was $8M.
HC Surgical Specialists Overview
About HC Surgical Specialists
HC Surgical Specialists is a Singapore medical services group listed on the Catalist board of the Singapore Exchange (SGX: 1B1) that provides endoscopic procedures, chiefly gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures. The company was incorporated on 1 September 2015 and listed on 3 November 2016. With its subsidiaries and associated companies it runs a network of 20 Medisave-accredited clinics and endoscopy centres in central Singapore and in residential estates such as Ang Mo Kio, Toa Payoh, Tampines and Bukit Batok, while major surgeries are performed at private hospitals including Mount Elizabeth, Mount Elizabeth Novena, Mount Alvernia and Farrer Park. Conditions treated include colorectal and stomach cancer, haemorrhoids, hernias and gallstones. The group has broadened into other specialties: in its 2026 financial year it bought 51% of Chirurgia Pte. Ltd., the practice of a hepato-pancreato-biliary surgeon, and on 20 October 2026 it acquired the remaining 65% of Total Orthopaedics Pte. Ltd., first invested in during 2023, for about SGD 21.4 million in cash payable over seven years, adding four orthopaedic centres.
Founded
2015
HQ
Employees
29
Website
Sectors
Financials (Last FY)
EV
$36M
Valuation Multiples
Start free trialHC Surgical Specialists Financials
HC Surgical Specialists reported last fiscal year revenue of $15M and EBITDA of $8M.
In the same fiscal year, HC Surgical Specialists generated $13M in gross profit, $8M in EBITDA, and $5M in net income.
HC Surgical Specialists P&L
In the most recent fiscal year, HC Surgical Specialists reported revenue of $15M and EBITDA of $8M.
HC Surgical Specialists is profitable as of last fiscal year, with gross margin of 84%, EBITDA margin of 50%, and net margin of 36%.
Financial data powered by Morningstar, Inc.
HC Surgical Specialists Stock Performance
HC Surgical Specialists has current market cap of $41M, and enterprise value of $36M.
Market Cap Evolution
HC Surgical Specialists' stock price is $0.27.
HC Surgical Specialists has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36M | $41M | 0.1% | - | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHC Surgical Specialists Valuation Multiples
HC Surgical Specialists trades at 2.4x EV/Revenue multiple, and 4.8x EV/EBITDA.
HC Surgical Specialists Financial Valuation Multiples
As of October 31, 2026, HC Surgical Specialists has market cap of $41M and EV of $36M.
HC Surgical Specialists has a P/E ratio of 7.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HC Surgical Specialists Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HC Surgical Specialists Margins & Growth Rates
In the most recent fiscal year, HC Surgical Specialists reported gross margin of 84%, EBITDA margin of 50%, and net margin of 36%.
HC Surgical Specialists Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
HC Surgical Specialists Operational KPIs
HC Surgical Specialists' revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
HC Surgical Specialists Competitors
HC Surgical Specialists competitors include Lokman Hekim, Egepol Hastaneleri, Sudmedica, Max Sight Group Holdings, Medcorp, Clinica de Marly, FamiCord, One Health Group, Gesundheitswelt Chiemgau and Emyria.
Most HC Surgical Specialists public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $85M | $14M | 1.2x | - | 7.4x | - | |||
| $27M | $3M | 1.2x | - | 9.6x | - | |||
| $166K | ($291K) | 215.4x | - | (122.5x) | - | |||
| $6M | $894K | 5.7x | - | 35.9x | - | |||
| - | - | - | - | - | - | |||
| - | - | - | - | - | - | |||
| $99M | $6M | 0.6x | 0.7x | 10.9x | 5.8x | |||
| $42M | $3M | 1.0x | 1.0x | 12.4x | 12.3x | |||
This data is available for Pro users. Sign up to see all HC Surgical Specialists competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by HC Surgical Specialists
HC Surgical Specialists has acquired 2 companies to date.
Last acquisition by HC Surgical Specialists was on October 20th 2026. HC Surgical Specialists acquired Total Orthopaedics for $26M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by HC Surgical Specialists
| Description | Total Orthopaedics is a private musculoskeletal medical group based in Singapore. The practice treats conditions of the bones, joints and muscles through orthopaedic specialists, and its website cites more than 15 years of experience. Patients book consultations through the clinic, and revenue comes from fees for medical consultations and treatment. | Singapore-based Medical L & C Services Pte delivers chronic home care and palliative services to patients. |
| HQ Country | ||
| HQ City | Singapore | Singapore |
| Deal Date | 20 Oct 2026 | 5 Jun 2017 |
| Valuation | $26M | $1M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all HC Surgical Specialists acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by HC Surgical Specialists
HC Surgical Specialists has invested in 1 company to date.
Latest investment by HC Surgical Specialists was on May 31st 2019. HC Surgical Specialists invested in Medistar Services in their $400K Strategic investment round (EV/Revenue multiple available to Pro users).
Latest Investments by HC Surgical Specialists
| Description | Medistar Services is a Singapore operator of The Ming Clinic at Camden Medical Centre, providing general practice services including family medicine, chronic disease management, and vaccinations to expatriates and locals in the Orchard Road district. |
| HQ Country | |
| HQ City | Singapore |
| Deal Date | 31 May 2019 |
| Round | Strategic investment |
| Raised | $400K |
| Investors | HC Surgical Specialists |
| Valuation | $1M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all HC Surgical Specialists investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HC Surgical Specialists
| When was HC Surgical Specialists founded? | HC Surgical Specialists was founded in 2015. |
| Where is HC Surgical Specialists headquartered? | HC Surgical Specialists is headquartered in Singapore. |
| How many employees does HC Surgical Specialists have? | As of today, HC Surgical Specialists has over 29 employees. |
| Is HC Surgical Specialists publicly listed? | Yes, HC Surgical Specialists is a public company listed on Singapore Exchange. |
| What is the stock symbol of HC Surgical Specialists? | HC Surgical Specialists trades under 1B1 ticker. |
| When did HC Surgical Specialists go public? | HC Surgical Specialists went public in 2016. |
| Who are competitors of HC Surgical Specialists? | HC Surgical Specialists main competitors include Lokman Hekim, Egepol Hastaneleri, Sudmedica, Max Sight Group Holdings, Medcorp, Clinica de Marly, FamiCord, One Health Group, Gesundheitswelt Chiemgau, Emyria. |
| What is the current market cap of HC Surgical Specialists? | HC Surgical Specialists' current market cap is $41M. |
| What is the current revenue of HC Surgical Specialists? | HC Surgical Specialists' last fiscal year revenue is $15M. |
| What is the current EV/Revenue multiple of HC Surgical Specialists? | Current revenue multiple of HC Surgical Specialists is 2.4x. |
| Is HC Surgical Specialists profitable? | No, HC Surgical Specialists is not profitable. |
| How many companies HC Surgical Specialists has acquired to date? | As of October 2026, HC Surgical Specialists has acquired 2 companies. |
| What was the largest acquisition by HC Surgical Specialists? | $26M acquisition of Total Orthopaedics on 20th October 2026 was the largest M&A HC Surgical Specialists has done to date. |
| What companies HC Surgical Specialists acquired? | HC Surgical Specialists acquired Total Orthopaedics and Medical L & C Services Pte. |
| In how many companies HC Surgical Specialists has invested to date? | As of October 2026, HC Surgical Specialists has invested in 1 company. |
| What was the last HC Surgical Specialists investment? | On 31st May 2019 HC Surgical Specialists invested in Medistar Services, participating in a $400K Strategic investment round at $1M valuation. |
| In what companies HC Surgical Specialists invested in? | HC Surgical Specialists invested in Medistar Services. |
See public comps similar to HC Surgical Specialists
Lists including HC Surgical Specialists
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




